YongTae Kim | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,138 results for “YongTae Kim”

Trials

View all 1137 →

Comparing KIM to TVT Exact Sling

147 participants · First posted Aug 2, 2021

Urinary NGAL and KIM-1 After ESWL

50 participants · First posted Jan 14, 2026

Active, not recruiting

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

32 participants · First posted Dec 7, 2016

Drugs

View all 540 →

KIM-127

SYX-KIM

Expanded Activated Lymphocytes (Beijing Yongtai)

Manufacturer: Immunotech-B (Beijing Yongtai)

Conditions: liver cancer

Organizations

View all 39 →

Kim, Edward

United States

HYUNJOONG KIM

Australia

KYUNGMI KIM

Australia

News

View all 422 →

MEPSGEN Launches NanoCalibur™ in US: Advanced Microfluidic Platform for Scalable Nanoparticle Production

KIM-1 Emerges as Promising Prognostic Biomarker in Advanced Renal Cell Carcinoma

PD-L1 and KIM-1 Expression Predict Outcomes in Adjuvant Nivolumab Treatment for ccRCC

Page 1 of 214